BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Biotech Bay

  BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership

  BioCardia, Inc. and StemCardia, Inc. announced a long-term partnership to advance StemCardia’s investigational pluripotent stem cell product candidate for the treatment of heart failure.

  March 13, 2024

   · 

  4 min read
• FDA

  Ventris Medical Receives 510(k) Additional Clearance for Amplify® Standalone Bone Graft Putty

  Ventris Medical today announced that the United States Food and Drug Administration has granted 510(k) clearance in the intervertebral disc space for Synthetic Bone Graft Putty (Amplify®).

  March 13, 2024

   · 

  3 min read
• Business

  Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

  Silence Therapeutics plc today reported its financial results for the full year ended December 31, 2023, and reviewed recent business highlights.

  March 13, 2024

   · 

  10 min read
• BioMidwest

  Vanqua Bio to Present at the Stifel 2024 CNS Days Conference

  Vanqua Bio announced today that the company will participate in the Stifel 2024 CNS Days Conference, which is being held virtually March 19-20.

  March 13, 2024

   · 

  1 min read
• Pharm Country

  Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution

  Agile Therapeutics, Inc., a women’s healthcare company, announced that it has paid-off the remainder of its debt facility with Perceptive Advisors.

  March 13, 2024

   · 

  3 min read
• Biotech Bay

  AbTherx Partners with Single Cell Technology for First Antibody Discovery Campaigns

  AbTherx, Inc. and Single Cell Technology, Inc. announced that AbTherx selected Single Cell for its first antibody discovery campaigns.

  March 13, 2024

   · 

  4 min read
• Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement

  Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.

  March 13, 2024

   · 

  2 min read
• Business

  EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

  EDAP TMS SA, the global leader in robotic energy-based therapies, announced that it will release its financial results for the fourth quarter and full-year ended December 31, 2023, before the markets open on Wednesday, March 27th, 2024.

  March 13, 2024

   · 

  1 min read
• Pharm Country

  New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities

  BD, a leading global medical technology company, announced new data from a research study evaluating the impact of deploying automated dispensing cabinets in long-term care facilities and an off-site, long-term care pharmacy.

  March 13, 2024

   · 

  3 min read
• Business

  ProQR Announces Year End 2023 Operating and Financial Results

  ProQR Therapeutics NV. reported its financial and operating results for the year ended December 31, 2023, and provided a business update.

  March 13, 2024

   · 

  13 min read